| Bioactivity | AZ3391 is a potent inhibitor of PARP. AZ3391 is a quinoxaline derivative. PARP family of enzymes play an important role in a number of cellular processes, such as replication, recombination, chromatin remodeling, and DNA damage repair. AZ3391 has the potential for the research of diseases and conditions occurring in tissues in the central nervous system, such as the brain and spinal cord (extracted from patent WO2021260092A1, compound 23)[1]. | ||||||||||||
| Name | AZ3391 | ||||||||||||
| CAS | 2756333-42-1 | ||||||||||||
| Formula | C23H27FN6O2 | ||||||||||||
| Molar Mass | 438.50 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Martin John Packer, et al. Quinoxaline derivatives as anti-cancer drugs. Patent WO2021260092A1. |
AZ3391
CAS: 2756333-42-1 F: C23H27FN6O2 W: 438.50
AZ3391 is a potent inhibitor of PARP. AZ3391 is a quinoxaline derivative. PARP family of enzymes play an important role
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.